According to a recent news article from NJ.com, the president and founder of OtisMed Corp. recently admitted to shipping hundreds of artificial knee products without FDA approval and pleaded guilty to criminal charges. Authorities are reporting defendant pleaded to guilty to three misdemeanor fraud counts related to a shipment of…
Product Liability Lawyer Blog
Brinkley v. Pliva, Inc.: Defective Generic Drug Lawsuits
Brinkley v. Pliva, Inc., a defective drugs case from the United States Court of Appeals for the Eighth Circuit, involved plaintiff whose doctor prescribed the brand-name drug Reglan to treat her Gastro Esophageal Reflux Disease (GERD). Plaintiff’s pharmacist substituted the generic drug metoclopramide, which was manufactured by defendant. This occurred…
Two Years After NECC Meningitis Outbreak, the Aftermath of The Tragedy Continues
In 2012, a meningitis outbreak was traced to a New England compounding facility. As our Boston product liability lawyers wrote at the time, multiple drugs were linked to the meningitis outbreak. More than two years later, many of the victims and their family members are still trying to get justice…
Framingham Compounding Pharmacy Owners Charged with Murder
According to a recent news article from CBS Boston, the founders of a Framingham compounding pharmacy and 12 other employees have been charged with racketeering and second-degree murder. Court papers indicated the compounding pharmacy was only licensed to manufacture small numbers of specific drugs for individual patients. This is the…
New Studies Examine the Appropriateness of Total Knee Replacement Surgery
A new article from the New York Times suggests that patients should be careful before agreeing to undergo total knee replacement. Patients who suffer from sore knees and have trouble getting around may give in too quickly to the temptations of having an artificial knee implanted. The device manufacturers have…
Scott v. C.R. Bard, Inc.: On Transvaginal Mesh Injuries
Scott v. C.R. Bard, Inc., an appeal from the Court of Appeal for the State of California, involved a plaintiff who was injured by a polypropylene mesh kit designed to treat women who suffer from a condition known as pelvic organ prolapse (POP). POP occurs when a female patient has…
Risks of Testosterone Replacement Therapy
Over the past decade, there has been a huge increase in the number of patients taking testosterone replacement therapy (TRT) drugs. A recent news article from IndyStar examines whether TRT drugs are a virtual fountain of youth or simply an increased risk for a having a heart attack. Drug companies…
Xarelto Plaintiffs Push For Consolidation of Numerous Lawsuits
Xarelto is a member of class of drugs known as New Oral Anticoagulants (NOACs) and has been the subject of many recent dangerous drug lawsuits. The makers of Xarelto (Bayer AG and Johnson & Johnson) produced a drug linked to serious clotting disorders, internal bleeding, and intracranial bleeding. Patients were…
FDA Delays Rule on Generic Drug Warnings
Drug manufacturers have an obligation to alert patients to any potential side effects associated with a particular medication. However, because of the way the laws are written, those who make and distribute generic drugs are actually prevented by law from alerting the public to potential problems. The U.S. Food and…
Stryker Agrees to Billion Dollar Settlement for Defective Hip Products
Stryker is one of many manufacturers working to resolve complaints arising from the sale of metal-on-metal hip implant products. According to Market Watch, Stryker has now agreed to settle many of the claims pending against the company. An estimated $1 billion will be provided to certain victims of defective hip…